Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Sanwa describes preclinical pharmacology of SKL-18287 and SKL-19014

July 12, 2010

Oramed and sanofi-aventis enter agreement for oral insulin capsules

July 9, 2010

Evatanepag accelerates fracture healing in phase II trial

July 9, 2010

TRUST trial further explores efficacy and safety of corifollitropin alfa

July 9, 2010

FDA grants orphan drug status to SBC-102 for lysosomal acid lipase deficiency

July 8, 2010

NOXXON to begin phase Ib trial of NOX-E36 for diabetes

July 8, 2010

BioMimetic reports on Augment bone graft trials

July 8, 2010

Dosing initiated in phase I trial of ALN-TTR01 for TTR-mediated amyloidosis

July 8, 2010

Chewable Lipitor obtains European approval for use in children

July 8, 2010

ZP-2929 shows promise in preclinical models of obesity and type 2 diabetes

July 7, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...